Skip to main content
Year archive

ABL Bio Inc. — 2023 filings

All 42 regulatory filings released by ABL Bio Inc. (298380) in 2023, sourced directly from the official regulator.

42 Filings
2023 Period
2023 filings (42)
Filing Released Lang
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-12-26 Korean
투자판단관련주요경영사항(임상시험계획변경승인신청)(이중항체 파킨슨병 치료제 ABL301의 미국 FDA 제1상 임상시험계획 (IND) 변경 신청)
Legal Proceedings Report
2023-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-15 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-10 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-10-23 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-10-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-10-06 Korean
주요사항보고서(유형자산양수결정)
M&A Activity
2023-09-08 Korean
투자판단관련주요경영사항(신규 항체-약물 결합체(ADC) 연구개발을 위한 기술도입 계약 체결)
Regulatory Filings
2023-09-07 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-08-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-08-28 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-08-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-08-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-08-18 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-11 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(이중항체 면역항암제 ABL103의 국내 제1상 임상시험계획 (IND) 승인)
Regulatory Filings
2023-08-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-07-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-07-04 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(이중항체 면역항암제 ABL103의 국내 제1상 임상시험계획 (IND) 승인 신청)
Regulatory Filings
2023-06-29 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-05-31 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-05-24 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-05-24 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-05-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-30 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-30 Korean
투자판단관련주요경영사항(이중항체 면역항암제 ABL503의 국내 제1상 임상시험계획 (IND) 승인)
Legal Proceedings Report
2023-03-29 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2023-03-15 Korean
주주총회집중일개최사유신고
AGM Information
2023-03-15 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-15 Korean
주주총회소집공고
AGM Information
2023-03-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-15 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-14 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-10 Korean
투자판단관련주요경영사항(이중항체 면역항암제 ABL503의 국내 제1상 임상시험계획 (IND) 신청)
Legal Proceedings Report
2023-02-07 Korean
불성실공시법인미지정
Legal Proceedings Report
2023-02-03 Korean
불성실공시법인지정예고(공시불이행)
Legal Proceedings Report
2023-01-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-01-06 Korean
투자판단관련주요경영사항(ABL301 관련 마일스톤 기술료 수령)
Regulatory Filings
2023-01-02 Korean